Cairo - Mubasher: Kahira Pharmaceuticals reported an increase of 5% to EGP 19.1 million in net profits for the first four months of the fiscal year 2015/16.
The company saw net profits of EGP 18.2 million for the same period a year earlier.
The drug producer's top line stood at EGP 163.6 million for this four-month period, up from EGP 144.3 million for the same period last year.
The firm earlier reported net profits of EGP 14.086 million for the first quarter of the fiscal year 2015/16, up from EGP 13.197 million for the year-ago period.
